Corteva, Inc. (NYSE:CTVA – Get Free Report) saw some unusual options trading activity on Thursday. Investors acquired 2,661 call options on the company. This represents an increase of approximately 149% compared to the average volume of 1,070 call options.
Corteva Stock Up 2.4%
CTVA stock opened at $9.41 on Friday. Corteva has a twelve month low of $9.01 and a twelve month high of $90.97. The company has a current ratio of 1.56, a quick ratio of 1.10 and a debt-to-equity ratio of 0.14. The company has a market capitalization of $6.28 billion, a P/E ratio of 4.96, a PEG ratio of 1.72 and a beta of 0.58. The firm has a 50 day simple moving average of $37.22 and a 200-day simple moving average of $69.57.
Corteva (NYSE:CTVA – Get Free Report) last issued its quarterly earnings results on Wednesday, November 11th. The company reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.02 by $0.04. The business had revenue of $2.46 billion during the quarter, compared to analyst estimates of $1.77 billion. Corteva had a net margin of 7.58% and a return on equity of 10.76%. The business’s revenue was down 8.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.23) earnings per share. Corteva has set its FY 2026 guidance at 0.760-0.800 EPS. On average, equities research analysts predict that Corteva will post 0.78 earnings per share for the current fiscal year.
Corteva Cuts Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Tuesday, December 1st will be given a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend is Tuesday, December 1st. This is a decrease from Corteva’s previous quarterly dividend of $0.18. Corteva’s payout ratio is presently 47.68%.
Latest Corteva News
Here’s some of the latest news about CTVA:
- Positive Sentiment: Corteva pointed to new products and cost-cutting efforts as supports for a potential recovery, though these measures have not offset near-term weakness. Corteva Q3 Earnings Call Highlights Brazil Woes and Outlook Cut
- Neutral Sentiment: Several analysts lowered price targets following the outlook reset. Citigroup and UBS kept neutral ratings, while JPMorgan maintained overweight and RBC kept outperform ratings, signaling some analysts still see potential upside from recent levels. Read More. · Read More. · Read More. · Read More.
- Negative Sentiment: The earnings miss and lowered full-year outlook are the key near-term headwinds, with Brazil weakness and competitive pricing hurting results. Reuters report on Brazil weakness and forecast cut
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on CTVA shares. Mizuho set a $16.00 target price on Corteva in a report on Thursday. Weiss Ratings downgraded shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. Oppenheimer lowered shares of Corteva from an “outperform” rating to a “market perform” rating in a report on Friday. Citigroup reduced their price target on shares of Corteva from $13.65 to $10.30 and set a “neutral” rating on the stock in a research report on Friday. Finally, Bank of America boosted their price objective on shares of Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a research note on Monday, July 20th. Fifteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Corteva presently has an average rating of “Moderate Buy” and a consensus price target of $52.60.
Read Our Latest Stock Analysis on CTVA
Institutional Investors Weigh In On Corteva
Institutional investors have recently modified their holdings of the stock. EFG International AG bought a new position in shares of Corteva during the second quarter worth about $25,000. Compass Financial Management LLC bought a new stake in Corteva in the second quarter valued at about $25,000. Elevation Wealth Partners LLC increased its holdings in Corteva by 334.6% in the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after buying an additional 261 shares during the last quarter. Clearstead Trust LLC acquired a new stake in Corteva during the second quarter valued at approximately $31,000. Finally, N.E.W. Advisory Services LLC acquired a new stake in Corteva during the second quarter valued at approximately $33,000. Institutional investors and hedge funds own 81.54% of the company’s stock.
Corteva Company Profile
Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.
Featured Stories
- Five stocks we like better than Corteva
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
